MiR-200c-5p inhibition could reduce the effects of SnHG12 downregulation on cell viability and apoptosis, without affecting SnHG12 expression levels in renal cell carcinoma (57). Here, SNHG12 is linked to hereditary clear cell renal cell carcinoma.